Recombinant Human Anterior Gradient 2 (AGR2)
Recombinant Human Anterior Gradient 2 (AGR2) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens) . Target Name: Anterior Gradient 2 (AGR2) . Target Synonyms: GOB4; HAG2; XAG2; AG2; PDIA17; HPC8; Anterior Gradient Protein 2; Protein Disulfide Isomerase Family A, Member 17; Secreted cement gland protein XAG-2 homolog. Accession Number: O95994. Gene ID: 10551. Expression Region: Arg21~Leu175. Tag Info: N-terminal His Tag. Theoretical MW: 22kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
CAS Number
9000-83-3
Short Description
Recombinant Human Anterior Gradient 2 (AGR2) is a purified Prokaryotic Protein.
Gene ID
10551
Accession Number
O95994
Expression Region
Arg21~Leu175
Expression System
Prokaryotic Expression
Host
E. coli
Target
Anterior Gradient 2 (AGR2)
Conjugation
Unconjugated
Tag
N-Terminal His Tag
Applications
Positive Control, Immunogen, SDS-PAGE, WB
Field of Research
Tumor Immunity
Endotoxin
<1.0EU/ug, by the LAL method
Purity
>90% by SDS-PAGE
Activity
Not Tested
Format
Freeze-dried powder
Buffer
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
22kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
Species
Human (Homo sapiens)
Protein Name
Prokaryotic Protein
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Human Polyclonal Human IgA Lambda Isotype Control [DyLight 405]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
Human Polyclonal Human IgA Lambda Isotype Control [DyLight 405]
Nudt1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Anti-CTLA-4/CD152 Antibody (Antitope patent anti-CTLA4)
